Plan debates usually return to scheduling and bans. India and the United States each confront versions of the same query: regardless of whether to impose broader, class-vast controls in excess of fentanyl analogs and their precursors, or to help keep substance-by-substance scheduling which can lag powering traffickers’ innovation.What's the bare